The Medical Countermeasure Systems (MCS) Joint Project Management office leads the effort to develop and acquire safe, effective, and innovative medical solutions and systems to combat chemical, biological, radiological, and nuclear (CBRN) threats and emerging infectious diseases and to protect and preserve the lives of our operating forces. MCS specializes in advanced development — that is, the office develops only those drugs that are beyond the R&D stage (for example, that are in Phase 1 clinical trials or that already have an FDA Investigational New Drug application on file).
Provide U.S. military forces and the nation safe, effective, and innovative medical solutions to counter CBRN threats.
A U.S. military force that has a full medical countermeasure capability to fight and win in any CBRN battle space worldwide.
Joint Product Management Offices